US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YARROW BIOSCIENCE, INC.

36.43

-1.7750-4.65%

Post-market: 36.430.00000.00%19:30 EDT

Volume:25.98K

Turnover:943.97K

Market Cap:97.25M

PE:-1.67

High:38.38

Open:37.00

Low:35.50

Close:38.20

52wk High:46.95

52wk Low:14.03

Shares:2.67M

Float Shares:611.50K

Volume Ratio:1.38

T/O Rate:4.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-21.8600

EPS(LYR):-66.8179

ROE:--

ROA:--

PB:-1.37

PE(LYR):-0.55

Loading ...

Overview Company News Filings

Company Profile

Company Name:

YARROW BIOSCIENCE, INC.

Exchange:

NASDAQ

Establishment Date:

2025

Employees:

7

Office Location:

40 10 th Avenue,Floor 7,New York,New York,United States

Website:

http://www.yarrowbioscience.com

Zip Code:

10014

Phone:

- -

Fax:

- -

Introduction:

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions. The company's lead product is VYN201, a locally administered pan- bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor for the treatment of immuno-inflammatory indications. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Directors

Name

Position

Bill Lundberg

Chairman of the Board and Director

Rebecca Frey

Chief Executive Officer and Director and President

Mona Ashiya

Director

Peter Silverman

Director

Steven Hoerter

Director

William White

Director

Shareholders

Name

Position

Rebecca Frey

Chief Executive Officer and Director and President

Rachael Alford

Chief Operating Officer

Tyler Zeronda

Chief Financial Officer

Lori Payton

Chief Development Officer

Steven Ryder

Chief Medical Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/YARW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"YARW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YARW\",,,,,undefined,":{"symbol":"YARW","market":"US","secType":"STK","nameCN":"YARROW BIOSCIENCE, INC.","latestPrice":36.425,"timestamp":1787342400000,"preClose":38.2,"halted":0,"volume":25981,"hourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04646596858638758,"floatShares":611500,"shares":2669800,"eps":-21.86,"marketStatus":"Market Closed","change":-1.775,"latestTime":"08-21 16:00:00 EDT","open":37,"high":38.38,"low":35.5,"amount":943966.2960069999,"amplitude":0.075393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-21.86,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":38.2,"postHourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3824092677883641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YARW\",,,,,undefined,":{"symbol":"YARW","floatShares":611500,"roa":"--","roe":"--","lyrEps":-66.817882,"volumeRatio":1.3824092677883641,"shares":2669800,"dividePrice":0,"high":38.38,"amplitude":0.075393,"preClose":38.2,"low":35.5,"week52Low":14.025,"pbRate":"-1.37","week52High":46.95,"institutionHeld":0,"latestPrice":36.425,"eps":-21.86,"divideRate":0,"volume":25981,"delay":0,"ttmEps":-21.86,"open":37,"prevYearClose":29.005,"prevWeekClose":42.49,"prevMonthClose":35.02,"prevQuarterClose":32.535,"fiveDayClose":42.49,"twentyDayClose":25.45,"sixtyDayClose":33.995},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YARW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"YARW","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.14},{"market":"US","date":"2026-07-27","symbol":"YARW","defaultRemindTime":1785159000000,"type":"split","dateTimestamp":1785124800000,"forFactor":50,"toFactor":1,"ratio":50},{"date":"2026-07-24","symbol":"YARW","amount":0.40242,"announcedDate":"2026-07-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-22","defaultRemindTime":1784899800000,"name":"VYNE Therapeutics Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-23","payableDate":"2026-07-22","currency":"USD","dateTimestamp":1784865600000,"payDate":"2026-07-23"},{"market":"US","date":"2026-05-15","symbol":"YARW","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-02-27","symbol":"YARW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772182800000,"name":null,"time":"Pre-MKt","dateTimestamp":1772168400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YARW\",market:\"US\",,,undefined,":[{"executeDate":"2026-07-24","recordDate":"2026-07-22","paymentDate":"2026-07-23","value":0.40242,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YARW\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1786680000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YARW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YARW","date":"2026-08-21","current":-1.666285,"percent":1,"low":-0.423388,"twenty":-0.421318,"median":-0.411606,"eighty":-0.406626,"high":-0.376652,"avg":-0.410215,"sd":0.013222,"marketCap":106960000},"quantilePoints":[{"date":"2026-08-14","current":-0.421219,"twenty":-0.422047,"median":-0.421219,"eighty":-0.412759,"marketCap":119616000},{"date":"2026-08-21","current":-0.376652,"twenty":-0.421318,"median":-0.411606,"eighty":-0.406626,"marketCap":106960000}],"updateTime":1787453670211},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1974571740,"yearFounded":2025,"employeeNum":7,"address":"40 10 th Avenue,Floor 7,New York,New York,United States","zipCode":"10014","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.yarrowbioscience.com","stockEarnings":[{"period":"1week","weight":-0.1427},{"period":"1month","weight":-0.1884},{"period":"3month","weight":0.085},{"period":"6month","weight":0.2248},{"period":"1year","weight":1.2568},{"period":"ytd","weight":0.2558}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions. The company's lead product is VYN201, a locally administered pan- bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor for the treatment of immuno-inflammatory indications. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.037101},{"month":2,"riseRate":0.444444,"avgChangeRate":0.014686},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.004341},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.154087},{"month":5,"riseRate":0.555556,"avgChangeRate":0.00572},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.050475},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.128315},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.071725},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023153},{"month":10,"riseRate":0.5,"avgChangeRate":0.011012},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029442},{"month":12,"riseRate":0.375,"avgChangeRate":-0.029662}],"exchange":"NASDAQ","name":"YARROW BIOSCIENCE, INC.","nameEN":"YARROW BIOSCIENCE, INC."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"YARW\",market:\"US\",,,undefined,":{"directors":[{"name":"Bill Lundberg","position":"Chairman of the Board and Director"},{"name":"Rebecca Frey","position":"Chief Executive Officer and Director and President"},{"name":"Mona Ashiya","position":"Director"},{"name":"Peter Silverman","position":"Director"},{"name":"Steven Hoerter","position":"Director"},{"name":"William White","position":"Director"}],"executives":[{"name":"Rebecca Frey","position":"Chief Executive Officer and Director and President"},{"name":"Rachael Alford","position":"Chief Operating Officer"},{"name":"Tyler Zeronda","position":"Chief Financial Officer"},{"name":"Lori Payton","position":"Chief Development Officer"},{"name":"Steven Ryder","position":"Chief Medical Officer"}]}}}